CEBP:XETRA:XETRA-iShares VII PLC - iShares MSCI EMU USD Hedged ETF Acc (EUR)

ETF | Others |

Last Closing

USD 10.618

Change

-0.01 (-0.13)%

Market Cap

USD 0.20B

Volume

1.08K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.08 (-0.18%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-1.12 (-1.13%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.10 (+0.41%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.05 (-0.35%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.01 (-0.23%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.10 (-0.44%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.16 (-1.26%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.86 (+1.52%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.04 (-0.41%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.39 (+0.32%)

USD 12.26B

ETFs Containing CEBP:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.72% 80% B- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.72% 82% B 76% C+
Trailing 12 Months  
Capital Gain 9.08% 80% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.08% 81% B- 77% C+
Trailing 5 Years  
Capital Gain 111.85% 93% A 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 111.85% 93% A 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.49% 86% B+ 84% B
Dividend Return 15.49% 86% B+ 83% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.94% 62% D 70% C-
Risk Adjusted Return 155.86% 100% F 99% N/A
Market Capitalization 0.20B 52% F 40% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike